Validation of a modified clinical risk score to predict cancer-specific survival for stage II colon cancer

Many patients with stage II colon cancer will die of their disease despite curative surgery. Therefore, identification of patients at high risk of poor outcome after surgery for stage II colon cancer is desirable. This study aims to validate a clinical risk score to predict cancer-specific survival...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Oliphant, Raymond, Horgan, Paul G, Morrison, David S, McMillan, Donald C
Médium: Artigo
Jazyk:Inglês
Vydáno: BlackWell Publishing Ltd 2015
Témata:
Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4312121/
https://ncbi.nlm.nih.gov/pubmed/25487740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.352
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky